Filtruoti pagal Last updated date SelectPoIkiFrom - To Data Pabaigos data This week Šį mėnesį Last week Praeitą mėnesį Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Rezultatai (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement on Viramune (Nevirapine) - Severe and Life-Threatening Cutaneous and Hepatic Reactions 12 Balandis 2000News Committee for Proprietary Medicinal Products (CPMP) 58th plenary meeting 20 Kovas 2000Press release Committee for veterinary medicinal products: 53rd meeting 9 Kovas 2000Press releaseVeterinary Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 Vasaris 2000News Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 Vasaris 2000Press release Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Vasaris 2000News Committee for veterinary medicinal products: 52nd meeting 10 Vasaris 2000Press releaseVeterinary Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Sausis 2000News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 Sausis 2000Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 Sausis 2000Press releaseHumanRare diseases 1 … 362 363 364 365 366 Page 366 of 380 367 368 369 370 … 380
Public Statement on Viramune (Nevirapine) - Severe and Life-Threatening Cutaneous and Hepatic Reactions 12 Balandis 2000News
Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 Vasaris 2000News
Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 Vasaris 2000Press release
Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 Vasaris 2000News
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 Sausis 2000News
3rd meeting of the Committee for Orphan Medicinal Products 19 Sausis 2000Press releaseHumanRare diseases
